Why the study?
Are plasma levels of HMGB1 associated with severity, mortality, and necroptosis markers in critically-ill patients with sepsis?
Are plasma levels of HMGB1 associated with severity, mortality, and necroptosis markers in critically-ill patients with sepsis?
Plasma HMGB1 levels are significantly associated with sepsis severity, 90-day mortality, and necroptosis markers RIPK3 and MLKL.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: